Showing results (71-80 of 1,478) with videos related to
Sort By:
Pageof 148
Human Psychopharmacology|December 31, 2009
Alterations in cortical activity of male methamphetamine abusers performing an empathy task: fMRI studyYang-Tae Kim, Jae-Jun Lee, Hui-Jin Song, et al.Human Psychopharmacology|December 13, 2005
A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action statusP Ken GillmanHuman Psychopharmacology|December 13, 2005
Biochemical profile in patients with anxious depression under the treatment with serotonergic antidepressants with different mechanisms of actionMarat G Uzbekov, Eduard Y Misionzhnik, Natella M Maximova, et al.Human Psychopharmacology|December 6, 2005
Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatmentHasan Herken, Omer Akyol, H Ramazan Yilmaz, et al.Human Psychopharmacology|March 31, 2018
Low serum level of epidermal growth factor in chronic ketamine usersMinling Zhang, Hongbo He, Yuping Ning, et al.Human Psychopharmacology|February 9, 2018
Serum levels of interleukin 6 in schizophrenic patients during treatment augmentation with sarcosine (results of the PULSAR study)Dominik Strzelecki, Małgorzata Urban-Kowalczyk, Adam WysokińskiHuman Psychopharmacology|November 30, 2018
Effect of GAD1 genotype status on auditory attention and acute nicotine administration in healthy volunteersEfthymios Hadjis, Molly Hyde, Joelle Choueiry, et al.Human Psychopharmacology|January 11, 2019
Treatments used for obsessive-compulsive disorder-An international perspectiveVlasios Brakoulias, Vladan Starcevic, Umberto Albert, et al.Human Psychopharmacology|November 28, 2018
The effects of different periods of co-administration of oral and long-acting injectable aripiprazole: A propensity score analysisMasakazu Hatano, Hiroyuki Kamei, Ippei Takeuchi, et al.Human Psychopharmacology|December 7, 2017
Higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: A [11 C]DASB PET studyJunhee Lee, Bo-Hyung Kim, Euitae Kim, et al.Pageof 148